🟢 Capricor Therapeutics is trading 8% up in after-hours trading with no clear company-specific catalyst identified

Capricor Therapeutics is trading at $9.24, up 7.82%, in after-hours trading, with no clear company-specific catalyst identified for the September 29 rise.

• Capricor Therapeutics had previously announced presentations of HOPE-3 and extension data at the World Muscle Society Congress, scheduled for September 29–October 3; the announcement does not establish a cause for the move.
• Major indices were mixed, with no broad-market move above 0.5% in the same direction. No volume or activity-level data was provided.